
Chiesi has been reprimanded after it breached the ABPI’s Code of Practice for its promotion of asthma inhaler Fostair. The …

A complaint made by a pulmonologist against the competence of Boehringer Ingelheim speakers during a congress held in Germany last …
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …

HRA Pharma has been slammed by the PMCPA after breaching six clauses of the ABPI Code of Practice in its …

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …
Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …

The Association of the British Pharmaceutical Industry has launched a new guide to explain how pharma and the NHS can …

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct. The complaint was …
Is UK pharma coping with the revised Code and what changes will 2009 bring?
The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …